However, the fact that the effects of the knockdown of SNHG8 were incompletely blocked by the miR-335-5p inhibitor, indicating the possible participation of other targets in the mechanism of SNHG8 in DLBCL. The gene discussed is SNHG8; the disease is diffuse large B-cell lymphoma.